Template:Infant fever well antibiotics: Difference between revisions
Ostermayer (talk | contribs) (Created page with "{| {{table}} | align="center" style="background:#f0f0f0;"|'''Suspected Infection Source''' | align="center" style="background:#f0f0f0;"|'''8-21 Days Old''' | align="center" style="background:#f0f0f0;"|'''22-28 Days Old''' | align="center" style="background:#f0f0f0;"|'''29-60 Days Old''' |- | UTI|| *Ampicillin IV or IM (150 mg/kg per day divided q8) AND either: **Ceftazidime IV or IM (150 mg/kg per day divided q8) or **Gentamicin IV or IM (4 mg/kg per do...") |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
===Neonatal Antibiotics by Source<ref>Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228 </ref>=== | |||
{| {{table}} | {| {{table}} | ||
| align="center" style="background:#f0f0f0;"|'''Suspected Infection Source''' | | align="center" style="background:#f0f0f0;"|'''Suspected Infection Source''' | ||
| Line 40: | Line 41: | ||
*AND [[Vancomycin]] IV (60 mg/kg QD) | *AND [[Vancomycin]] IV (60 mg/kg QD) | ||
|} | |} | ||
Latest revision as of 15:41, 30 July 2025
Neonatal Antibiotics by Source[1]
| Suspected Infection Source | 8-21 Days Old | 22-28 Days Old | 29-60 Days Old |
| UTI |
|
|
|
| No source identified |
|
|
|
| Bacterial meningitis |
|
|
|
- ↑ Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old Robert H. Pantell, Kenneth B. Roberts, William G. Adams, Benard P. Dreyer, Nathan Kuppermann, Sean T. O'Leary, Kymika Okechukwu and Charles R. Woods; Subcommittee On Febrile Infants Pediatrics July 2021, e2021052228; DOI: https://doi.org/10.1542/peds.2021-052228
